Clinical Research Directory
Browse clinical research sites, groups, and studies.
Berbevis Dose-finding Study in Subjects With Impaired Fasting Glucose
Sponsor: Azienda di Servizi alla Persona di Pavia
Summary
Assessing the effects of a nutraceutical supplement (Berbevis™) in adults with impaired fasting glucose (100-126 mg/dL) and BMI between 25 and 35. Ninety participants will be assigned to three parallel groups receiving Berbevis™ at increasing daily doses (500 mg, 750 mg, and 1000 mg) for 2 months.
Official title: Berbevis Project: Multitarget Dose-finding Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-06-15
Completion Date
2026-09-15
Last Updated
2025-11-25
Healthy Volunteers
No
Conditions
Interventions
Berbevis supplement
This intervention consists of a standardized oral dietary supplement containing Berberis aristata extract formulated in phospholipids (Berbevis™). The supplement is formulated to support metabolic balance. It is administered twice daily for 8 weeks to evaluate safety, tolerability, and dose-response effects in healthy adult volunteers.